Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease
In recent years the concept of psoriasis as a systemic disease has gained acceptance due to its association with numerous comorbid conditions, particularly atherosclerosis and cardiovascular disease. Several studies have shown that patients with psoriasis, especially younger patients and those with...
Gespeichert in:
Veröffentlicht in: | Actas dermo-sifiliográficas (English ed.) 2017-11, Vol.108 (9), p.800-808 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng ; spa |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 808 |
---|---|
container_issue | 9 |
container_start_page | 800 |
container_title | Actas dermo-sifiliográficas (English ed.) |
container_volume | 108 |
creator | Bonanad, C González-Parra, E Rivera, R Carrascosa, J M Daudén, E Olveira, A Botella-Estrada, R |
description | In recent years the concept of psoriasis as a systemic disease has gained acceptance due to its association with numerous comorbid conditions, particularly atherosclerosis and cardiovascular disease. Several studies have shown that patients with psoriasis, especially younger patients and those with more severe forms of psoriasis or with psoriatic arthritis, have a higher prevalence of risk factors and metabolic syndrome, as well as an increased risk of major cardiovascular events such as myocardial infarction, cerebrovascular disease, and peripheral arterial disease. Furthermore, it remains unclear which of the current treatments might be more effective in reducing cardiovascular risk in these patients. It is therefore important for dermatologists to be aware of this increased risk, to be able to detect modifiable risk factors early and, when appropriate, refer patients to other specialists for the prevention of major cardiovascular events. |
doi_str_mv | 10.1016/j.ad.2016.12.023 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1909745290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1909745290</sourcerecordid><originalsourceid>FETCH-LOGICAL-p103t-df6eaf6dd74790e68cfdfc6d05cf028da221f10172741bb3eb4df8408e61b85d3</originalsourceid><addsrcrecordid>eNotkElrwzAUhEWh0JDm3qOOPcSuFq_H4G6BQHtIyDE8S0-NgmK5fnZ_fw3taYZh-GCGsQcpUilk8XRJwaZqdqlUqVD6hi1kXlaJkrW4YyuiixBCKqlzLRfMNcF33kBY82cPX12k0Zs1h87y_RkH6HGaA7699mFujT52xH3HPykOHsgT3xBF42FEy49-PPMGBuvjD5CZAgwzlBAI79mtg0C4-tclO7y-7Jv3ZPfxtm02u6SXQo-JdQWCK6wts7IWWFTGWWcKK3LjhKosKCXdvLJUZSbbVmObWVdlosJCtlVu9ZI9_nH7IX5PSOPp6slgCNBhnOg0f1CXWa5qoX8B6zZbFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1909745290</pqid></control><display><type>article</type><title>Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease</title><source>Elsevier ScienceDirect Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Bonanad, C ; González-Parra, E ; Rivera, R ; Carrascosa, J M ; Daudén, E ; Olveira, A ; Botella-Estrada, R</creator><creatorcontrib>Bonanad, C ; González-Parra, E ; Rivera, R ; Carrascosa, J M ; Daudén, E ; Olveira, A ; Botella-Estrada, R</creatorcontrib><description>In recent years the concept of psoriasis as a systemic disease has gained acceptance due to its association with numerous comorbid conditions, particularly atherosclerosis and cardiovascular disease. Several studies have shown that patients with psoriasis, especially younger patients and those with more severe forms of psoriasis or with psoriatic arthritis, have a higher prevalence of risk factors and metabolic syndrome, as well as an increased risk of major cardiovascular events such as myocardial infarction, cerebrovascular disease, and peripheral arterial disease. Furthermore, it remains unclear which of the current treatments might be more effective in reducing cardiovascular risk in these patients. It is therefore important for dermatologists to be aware of this increased risk, to be able to detect modifiable risk factors early and, when appropriate, refer patients to other specialists for the prevention of major cardiovascular events.</description><identifier>EISSN: 1578-2190</identifier><identifier>DOI: 10.1016/j.ad.2016.12.023</identifier><language>eng ; spa</language><ispartof>Actas dermo-sifiliográficas (English ed.), 2017-11, Vol.108 (9), p.800-808</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Bonanad, C</creatorcontrib><creatorcontrib>González-Parra, E</creatorcontrib><creatorcontrib>Rivera, R</creatorcontrib><creatorcontrib>Carrascosa, J M</creatorcontrib><creatorcontrib>Daudén, E</creatorcontrib><creatorcontrib>Olveira, A</creatorcontrib><creatorcontrib>Botella-Estrada, R</creatorcontrib><title>Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease</title><title>Actas dermo-sifiliográficas (English ed.)</title><description>In recent years the concept of psoriasis as a systemic disease has gained acceptance due to its association with numerous comorbid conditions, particularly atherosclerosis and cardiovascular disease. Several studies have shown that patients with psoriasis, especially younger patients and those with more severe forms of psoriasis or with psoriatic arthritis, have a higher prevalence of risk factors and metabolic syndrome, as well as an increased risk of major cardiovascular events such as myocardial infarction, cerebrovascular disease, and peripheral arterial disease. Furthermore, it remains unclear which of the current treatments might be more effective in reducing cardiovascular risk in these patients. It is therefore important for dermatologists to be aware of this increased risk, to be able to detect modifiable risk factors early and, when appropriate, refer patients to other specialists for the prevention of major cardiovascular events.</description><issn>1578-2190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNotkElrwzAUhEWh0JDm3qOOPcSuFq_H4G6BQHtIyDE8S0-NgmK5fnZ_fw3taYZh-GCGsQcpUilk8XRJwaZqdqlUqVD6hi1kXlaJkrW4YyuiixBCKqlzLRfMNcF33kBY82cPX12k0Zs1h87y_RkH6HGaA7699mFujT52xH3HPykOHsgT3xBF42FEy49-PPMGBuvjD5CZAgwzlBAI79mtg0C4-tclO7y-7Jv3ZPfxtm02u6SXQo-JdQWCK6wts7IWWFTGWWcKK3LjhKosKCXdvLJUZSbbVmObWVdlosJCtlVu9ZI9_nH7IX5PSOPp6slgCNBhnOg0f1CXWa5qoX8B6zZbFA</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Bonanad, C</creator><creator>González-Parra, E</creator><creator>Rivera, R</creator><creator>Carrascosa, J M</creator><creator>Daudén, E</creator><creator>Olveira, A</creator><creator>Botella-Estrada, R</creator><scope>7X8</scope></search><sort><creationdate>20171101</creationdate><title>Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease</title><author>Bonanad, C ; González-Parra, E ; Rivera, R ; Carrascosa, J M ; Daudén, E ; Olveira, A ; Botella-Estrada, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p103t-df6eaf6dd74790e68cfdfc6d05cf028da221f10172741bb3eb4df8408e61b85d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonanad, C</creatorcontrib><creatorcontrib>González-Parra, E</creatorcontrib><creatorcontrib>Rivera, R</creatorcontrib><creatorcontrib>Carrascosa, J M</creatorcontrib><creatorcontrib>Daudén, E</creatorcontrib><creatorcontrib>Olveira, A</creatorcontrib><creatorcontrib>Botella-Estrada, R</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>Actas dermo-sifiliográficas (English ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonanad, C</au><au>González-Parra, E</au><au>Rivera, R</au><au>Carrascosa, J M</au><au>Daudén, E</au><au>Olveira, A</au><au>Botella-Estrada, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease</atitle><jtitle>Actas dermo-sifiliográficas (English ed.)</jtitle><date>2017-11-01</date><risdate>2017</risdate><volume>108</volume><issue>9</issue><spage>800</spage><epage>808</epage><pages>800-808</pages><eissn>1578-2190</eissn><abstract>In recent years the concept of psoriasis as a systemic disease has gained acceptance due to its association with numerous comorbid conditions, particularly atherosclerosis and cardiovascular disease. Several studies have shown that patients with psoriasis, especially younger patients and those with more severe forms of psoriasis or with psoriatic arthritis, have a higher prevalence of risk factors and metabolic syndrome, as well as an increased risk of major cardiovascular events such as myocardial infarction, cerebrovascular disease, and peripheral arterial disease. Furthermore, it remains unclear which of the current treatments might be more effective in reducing cardiovascular risk in these patients. It is therefore important for dermatologists to be aware of this increased risk, to be able to detect modifiable risk factors early and, when appropriate, refer patients to other specialists for the prevention of major cardiovascular events.</abstract><doi>10.1016/j.ad.2016.12.023</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1578-2190 |
ispartof | Actas dermo-sifiliográficas (English ed.), 2017-11, Vol.108 (9), p.800-808 |
issn | 1578-2190 |
language | eng ; spa |
recordid | cdi_proquest_miscellaneous_1909745290 |
source | Elsevier ScienceDirect Journals Complete; Alma/SFX Local Collection |
title | Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A21%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical,%20Diagnostic,%20and%20Therapeutic%20Implications%20in%20Psoriasis%20Associated%20With%20Cardiovascular%20Disease&rft.jtitle=Actas%20dermo-sifiliogr%C3%A1ficas%20(English%20ed.)&rft.au=Bonanad,%20C&rft.date=2017-11-01&rft.volume=108&rft.issue=9&rft.spage=800&rft.epage=808&rft.pages=800-808&rft.eissn=1578-2190&rft_id=info:doi/10.1016/j.ad.2016.12.023&rft_dat=%3Cproquest%3E1909745290%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1909745290&rft_id=info:pmid/&rfr_iscdi=true |